111 related articles for article (PubMed ID: 10344663)
1. Long-term persistence of cellular hyporesponsiveness to filarial antigens after clearance of microfilaremia.
Gopinath R; Hanna LE; Kumaraswami V; Pillai SV; Kavitha V; Vijayasekaran V; Rajasekharan A; Nutman TB
Am J Trop Med Hyg; 1999 May; 60(5):848-53. PubMed ID: 10344663
[TBL] [Abstract][Full Text] [Related]
2. Clearance of Wuchereria bancrofti antigen after treatment with diethylcarbamazine or ivermectin.
Eberhard ML; Hightower AW; Addiss DG; Lammie PJ
Am J Trop Med Hyg; 1997 Oct; 57(4):483-6. PubMed ID: 9347968
[TBL] [Abstract][Full Text] [Related]
3. Clearance of circulating filarial antigen as a measure of the macrofilaricidal activity of diethylcarbamazine in Wuchereria bancrofti infection.
McCarthy JS; Guinea A; Weil GJ; Ottesen EA
J Infect Dis; 1995 Aug; 172(2):521-6. PubMed ID: 7622896
[TBL] [Abstract][Full Text] [Related]
4. Prolonged clearance of microfilaraemia in patients with bancroftian filariasis after multiple high doses of ivermectin or diethylcarbamazine.
Ismail MM; Weil GJ; Jayasinghe KS; Premaratne UN; Abeyewickreme W; Rajaratnam HN; Sheriff MH; Perera CS; Dissanaike AS
Trans R Soc Trop Med Hyg; 1996; 90(6):684-8. PubMed ID: 9015519
[TBL] [Abstract][Full Text] [Related]
5. Ultrastructural analysis of microfilariae of Wuchereria bancrofti obtained from persistent carriers after repeated courses of diethylcarbamazine.
Alves LC; Cavalcanti MG; Araújo HR; Silva GM; Veras DL; Paiva MH; Brayner FA
Micron; 2009; 40(5-6):659-64. PubMed ID: 19359187
[TBL] [Abstract][Full Text] [Related]
6. Reduction of Wuchereria bancrofti adult worm circulating antigen after annual treatments of diethylcarbamazine combined with ivermectin in French Polynesia.
Nicolas L; Plichart C; Nguyen LN; Moulia-Pelat JP
J Infect Dis; 1997 Feb; 175(2):489-92. PubMed ID: 9203681
[TBL] [Abstract][Full Text] [Related]
7. Effects of ivermectin and diethylcarbamazine on microfilariae and overall microfilaria production in bancroftian filariasis.
Stolk WA; VAN Oortmarssen GJ; Pani SP; DE Vlas SJ; Subramanian S; DAS PK; Habbema JD
Am J Trop Med Hyg; 2005 Nov; 73(5):881-7. PubMed ID: 16282298
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of ivermectin for control of microfilaremia recurring after treatment with diethylcarbamazine. II. Immunologic changes following treatment.
Zheng HJ; Tao ZH; Cheng WF; Wang SH; Cheng SH; Ye YM; Luo LF; Chen XR; Gan GB; Piessens WF
Am J Trop Med Hyg; 1991 Aug; 45(2):175-81. PubMed ID: 1877712
[TBL] [Abstract][Full Text] [Related]
9. Stage-specific induction of cytokines regulates the immune response in lymphatic filariasis.
Mahanty S; Luke HE; Kumaraswami V; Narayanan PR; Vijayshekaran V; Nutman TB
Exp Parasitol; 1996 Nov; 84(2):282-90. PubMed ID: 8932778
[TBL] [Abstract][Full Text] [Related]
10. Comparison of single-dose diethylcarbamazine and ivermectin for treatment of bancroftian filariasis in Papua New Guinea.
Kazura J; Greenberg J; Perry R; Weil G; Day K; Alpers M
Am J Trop Med Hyg; 1993 Dec; 49(6):804-11. PubMed ID: 8279647
[TBL] [Abstract][Full Text] [Related]
11. Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children.
Addiss DG; Beach MJ; Streit TG; Lutwick S; LeConte FH; Lafontant JG; Hightower AW; Lammie PJ
Lancet; 1997 Aug; 350(9076):480-4. PubMed ID: 9274584
[TBL] [Abstract][Full Text] [Related]
12. Bancroftian filariasis in Haiti: preliminary characterization of the immunological responsiveness of microfilaremic individuals.
Lammie PJ; Leiva LE; Ruff AJ; Eberhard ML; Lowrie RC; Katz SP
Am J Trop Med Hyg; 1988 Jan; 38(1):125-9. PubMed ID: 3277457
[TBL] [Abstract][Full Text] [Related]
13. Changes in circulating parasite antigen levels after treatment of bancroftian filariasis with diethylcarbamazine and ivermectin.
Weil GJ; Lammie PJ; Richards FO; Eberhard ML
J Infect Dis; 1991 Oct; 164(4):814-6. PubMed ID: 1894943
[TBL] [Abstract][Full Text] [Related]
14. The serpin secreted by Brugia malayi microfilariae, Bm-SPN-2, elicits strong, but short-lived, immune responses in mice and humans.
Zang X; Atmadja AK; Gray P; Allen JE; Gray CA; Lawrence RA; Yazdanbakhsh M; Maizels RM
J Immunol; 2000 Nov; 165(9):5161-9. PubMed ID: 11046048
[TBL] [Abstract][Full Text] [Related]
15. Double blind study on efficacy and safety of single doses of ivermectin and diethylcarbamazine for treatment of Polynesian Wuchereria bancrofti carriers. Results at six months.
Cartel JL; Spiegel A; Nguyen L; Genelle B; Roux JF
Trop Med Parasitol; 1991 Mar; 42(1):38-40. PubMed ID: 2052854
[TBL] [Abstract][Full Text] [Related]
16. Model-based analysis of trial data: microfilaria and worm-productivity loss after diethylcarbamazine-albendazole or ivermectin-albendazole combination therapy against Wuchereria bancrofti.
de Kraker ME; Stolk WA; van Oortmarssen GJ; Habbema JD
Trop Med Int Health; 2006 May; 11(5):718-28. PubMed ID: 16640625
[TBL] [Abstract][Full Text] [Related]
17. Effect of a single dose of diethylcarbamazine, albendazole or both on the clearance of Wuchereria bancrofti microfilariae and antigenaemia among microfilaria carriers: a randomized trial.
Hoti SL; Pani SP; Vanamail P; Athisaya Mary K; Das LK; Das PK
Natl Med J India; 2010; 23(2):72-6. PubMed ID: 20925201
[TBL] [Abstract][Full Text] [Related]
18. Tolerability and efficacy of single dose diethylcarbamazine (DEC) alone or co-administration with Ivermectin in the clearance of Wuchereria bancrofti microfilaraemia in Pondicherry, South India.
Pani SP; Reddy GS; Vanamail P; Venkatesvarlou N; Das LK; Vijayan AP
J Commun Dis; 2004 Dec; 36(4):240-50. PubMed ID: 16506546
[TBL] [Abstract][Full Text] [Related]
19. Effect of two single doses of ivermectin in treatment of asymptomatic bancroftian filariasis in two villages in the Nile Delta, Egypt.
Youssef FG; Hassanein SH; Abdel-Fatah MS; el-Sharkawy IM
J Egypt Soc Parasitol; 1997 Apr; 27(1):83-92. PubMed ID: 9097530
[TBL] [Abstract][Full Text] [Related]
20. The effect of repeated half-yearly diethylcarbamazine mass treatment on Wuchereria bancrofti infection and transmission in two East African communities with different levels of endemicity.
Simonsen PE; Meyrowitsch DW; Mukoko DA; Pedersen EM; Malecela-Lazaro MN; Rwegoshora RT; Ouma JH; Masese N; Jaoko WG; Michael E
Am J Trop Med Hyg; 2004 Jan; 70(1):63-71. PubMed ID: 14971700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
